Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Acta Pharmaceutica
Volume 71 (2021): Numero 4 (December 2021)
Accesso libero
New derivatives of sulfonylhydrazone as potential antitumor agents: Design, synthesis and cheminformatics evaluation
Dima A. Sabbah
Dima A. Sabbah
,
Bara’a A. Al-Azaideh
Bara’a A. Al-Azaideh
,
Wamidh H. Talib
Wamidh H. Talib
,
Rima Hajjo
Rima Hajjo
,
Kamal Sweidan
Kamal Sweidan
,
Aya M. Al-Zuheiri
Aya M. Al-Zuheiri
,
Ghassan Abu Sheikha
Ghassan Abu Sheikha
e
Sawsan Shraim
Sawsan Shraim
| 03 apr 2021
Acta Pharmaceutica
Volume 71 (2021): Numero 4 (December 2021)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
03 apr 2021
Pagine:
545 - 565
Accettato:
08 dic 2020
DOI:
https://doi.org/10.2478/acph-2021-0043
Parole chiave
sulfonylhydrazones
,
antitumor
,
HCT-116
,
PI3Kα-inhibitors
,
cheminformatics
,
docking
© 2021 Dima A. Sabbah et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dima A. Sabbah
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan
Jordan
Bara’a A. Al-Azaideh
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan
Jordan
Wamidh H. Talib
Department of Clinical Pharmacy and Therapeutics, Applied Science Private University
Jordan
Rima Hajjo
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan
Jordan
Kamal Sweidan
Department of Chemistry, The University of Jordan
Jordan
Aya M. Al-Zuheiri
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan
Jordan
Ghassan Abu Sheikha
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan
Jordan
Visiting Professor Scholar, Skaggs School of Pharmacy and Pharmaceutical Science University of California
Sawsan Shraim
Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan
Jordan